Ovarian cancer is the most lethal gynaecological malignancy that presents at an advanced stage in 75% of patients. Ovarian cancer is predominantly a disease of older, postmenopausal women with the majority (>80%) of cases being diagnosed in women over 50 years. The exact cause of ovarian cancer remains unknown, but many associated risk factors haveContinue reading “Advanced Recurrent Ovarian Cancer Market, Epidemiology, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight“
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Healthcarewriter 